genetic-test-underused-in-cancer-care

A novel oncology instrument known as “comprehensive genetic profiling” continues to be significantly underutilized — even in specific cancers for which the assessment is clearly advised, researchers at Yale have discovered.


Leave a Reply

Your email address will not be published. Required fields are marked *

Share This